CNC vs OSCR
Centene Corporation and Oscar Health, Inc., both Healthcare
Centene Corporation is the larger company at $30B against $8.6B. Over the past year CNC returned +103% against +76% for OSCR. The RyuScore puts OSCR ahead, 45 against 27 out of 100.
| Figure | CNC | OSCR |
|---|---|---|
| Last close | $65.37 | $33.35 |
| Market cap | $30B | $8.6B |
| Trailing P/Elower is cheaper for the same earnings, not automatically better | n/a | 25.6 |
| 1-year return | +103% | +76% |
| 5-year return | +3.9% | +88% |
| RyuScoresector-relative, 1–10 | 27/100 | 45/100 |
Figures from SEC filings and end-of-day closes. Highlighting marks the higher or lower number, which is not the same as the better investment, a low P/E can be a warning and a high one can be deserved.
Centene Corporation
Revenue of $54B in Q2 2026, net income $1.1B. Its largest reported line is Medicaid, 52% of the disclosed total.
Oscar Health, Inc.
Revenue of $4.9B in Q2 2026, net income $362M.
Open these two in the interactive comparison to add more names, change the period or see the correlation.